BG Medicine, Inc. (BGMD) Posts Q4 Loss of 23c/Share, Narrower than Views

BG Medicine, Inc. (NASDAQ: BGMD) reported Q4 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $379 thousand versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on BG Medicine, Inc. (BGMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance